Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101075
Status:
TERMINATED
Last Update Posted:
2017-02-27
First Post:
2005-01-07
Brief Title:
Title XELOX FOR SALIVARY GLAND CANCERS
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Phase II Study of Capecitabine and Oxaliplatin XELOX in Patients With Locally Advanced Incurable Salivary Gland Cancers
Status:
TERMINATED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Slow Accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical research study is to find out how effective oxaliplatin and capecitabine are against advanced cancer of the salivary gland The safety of this treatment as well as how long the cancer responds or stays in a stable state due to the treatment will also be studied
Detailed Description:
This is a study of two investigational agents called oxaliplatin and capecitabine
Investigational agents have not received Food and Drug Administration FDA approval for the way they are being used in this study This means an investigation drug is still under study to determine what a safe dose is what the side effects are and whether or not it is effective in the disease or condition being studied
Oxaliplatin and capecitabine are chemotherapy agents that have been approved by the FDA for use in other cancers
Investigational agents have not received Food and Drug Administration FDA approval for the way they are being used in this study This means an investigation drug is still under study to determine what a safe dose is what the side effects are and whether or not it is effective in the disease or condition being studied
Oxaliplatin and capecitabine are chemotherapy agents that have been approved by the FDA for use in other cancers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SANOFI-DFCI-04149 | US NIH GrantContract | None | httpsreporternihgovquickSearchP30CA006516 |
| P30CA006516 | NIH | None | None |